134. Septo-optic dysplasia Disease details / Clinical trials / Drug dev / DR info /


Clinical trials : 3 /  Drugs : 3 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 3

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Actigraphy, blood and salivary sample, and sleep evaluation
   IRCCS National Neurological Institute C. Mondino Foundation
      2023   -   NCT06262152   Italy
Nutropin AQ
   Children's Hospital Los Angeles
      2004   Phase 4   NCT00140413   United States
Setmelanotide
   Rhythm Pharmaceuticals, Inc.
      2025   Phase 3   NCT06760546   United Kingdom;United States